Abstract
Purpose
The aim of this study is to prove the efficacy and safety of intrathecal baclofen therapy in infants and children below 6 years of age by retrospective analysis of our pediatric cohort of 135 primary pump implantations.
Methods
Between 2007 and 2018, 17 patients with pump implantations were below 6 years of age. Data were acquired retrospectively with a follow-up of 12 months to 11 years regarding complications.
Results
The youngest infant was 11 months at implantation with a bodyweight of 6, 4 kg, and 63 cm length. Surgical complications were comparable to published literature and mainly involved the catheter (2 catheter dislocations and 1 catheter transection) and one pump infection resulting in 4 revision surgeries in 3 patients. One baclofen-related apnea during titration and an overdose after refill were treated conservatively. Using a subfascial implantation technique, we observed neither skin ulceration nor pump infection since 2007. In a growing child, catheter slides are common and related to growth, scoliosis, spine surgery, and surgical failure.
Conclusion
Intrathecal baclofen therapy in infants and small children is as safe and effective as published for older pediatric patients; therefore, intrathecal baclofen can be considered in all infants as long as an 8-cm incision fits into the triangle of the anterior superior iliac spine, costal margin of the 10th rib, and navel. We suggest the utilization of subfascial surgical technique for implantation pump and catheter. Titration of intrathecal baclofen should be performed slowly to avoid bradycardia in infants. This is a retrospective study (level of evidence 4).
Similar content being viewed by others
References
Woolf SM, Baum CR (2017) Baclofen pumps: uses and complications. Pediatr Emerg Care 33(4):271–275
Abe T, Taniguchi W, Nishio N, Nakatsuka T, Yoshida M, Yamada H (2019) Molecular mechanisms of the antispasticity effects of baclofen on spinal ventral horn neurons. Neuroreport 30(1):19–25. https://doi.org/10.1097/WNR.0000000000001155
Flack SH, Bernards CM (2010) Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs. Anesthesiology 112(1):165–173
Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen therapy for spasticity in cerebral plasy. JAMA 265:1418–1422
Dickey MP, Rice M, Kinnett DG, Lambert R, Donauer S, Gerber MA, Staat MA (2013) Infectious complications of intrathecal baclofen pump devices in a pediatric population. Pediatr Infect Dis J 32(7):715–722. https://doi.org/10.1097/INF.0b013e318287f02a
Spader HS, Bollo RJ, Bowers CA, Riva-Cambrin J (2016) Risk factors for baclofen pump infection in children: a multivariate analysis. J Neurosurg Pediatr 17(6):756–762. https://doi.org/10.3171/2015.11.PEDS15421
Stewart K, Hutana G, Kentish M (2017) Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit. BMJ Open 7(6):e015863. https://doi.org/10.1136/bmjopen-2017-015863
Skalsky AJ, Fournier CM (2015) Intrathecal baclofen bolus dosing and catheter tip placement in pediatric tone management. Phys Med Rehabil Clin N Am 26(1):89–93. https://doi.org/10.1016/j.pmr.2014.09.011
Ammar A, Ughratdar I, Sivakumar G, Vloeberghs MH (2012) Intrathecal baclofen therapy--how we do it. J Neurosurg Pediatr 10(5):439–444
Motta F, Antonello CE (2014) Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr 13(3):301–306. https://doi.org/10.3171/2013.11
Berman CM, Eppinger MA, Mazzola CA (2015) Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity. Childs Nerv Syst 31(3):405–413
Buizer AI, Martens BHM, Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ (2019) Effect of continuous intrathecal baclofen therapy in children: a systematic review. Dev Med Child Neurol 61(2):128–134. https://doi.org/10.1111/dmcn.14005
Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL (2001) Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery. 49(3):753–756 discussion 756-7
Chan DY, Chan SS, Chan EK, Ng AY, Ying AC, Li AC, Chiu CC, Cheung N, Mak WK, Sun DT, Zhu CX, Poon WS (2018) Blessing or burden? Long-term maintenance, complications and clinical outcome of intrathecal baclofen pumps. Surg Pract 22(3):105–110. https://doi.org/10.1111/1744-1633.12308
Saulino M, Anderson DJ, Doble J, Farid R, Gul F, Konrad P, Boster AL (2016) Best practices for intrathecal baclofen therapy: troubleshooting. Neuromodulation 19(6):632–641. https://doi.org/10.1111/ner.12467
Fjelstad AB, Hommelstad J, Sorteberg A (2009) Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 4(5):487–493. https://doi.org/10.3171/2009.6.PEDS0921
Ghobrial GM, Thakkar V, Singhal S, Oppenlander ME, Maulucci CM, Harrop JS, Jallo J, Prasad S, Saulino M, Sharan AD (2014) Efficacy of intraoperative vancomycin powder use in intrathecal baclofen pump implantation procedures: single institutional series in a high risk population. J Clin Neurosci 21(10):1786–1789. https://doi.org/10.1016/j.jocn.2014.04.007
Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR, McLaughlin JF, Nadell J (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15(2):71–77
Pucks-Faes E, Hitzenberger G, Matzak H, Fava E, Verrienti G, Laimer I, Fritz J, Saltuari L (2018) Eleven years’ experience with Intrathecal Baclofen - complications, risk factors. Brain Behav 8(5):e00965. https://doi.org/10.1002/brb3.965
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hagemann, C., Schmitt, I., Lischetzki, G. et al. Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age. Childs Nerv Syst 36, 767–773 (2020). https://doi.org/10.1007/s00381-019-04341-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-019-04341-7